RSH-7
CAS No. 2764609-97-2
RSH-7 ( —— )
产品货号. M36539 CAS No. 2764609-97-2
RSH-7 是一种有效的 BTK 和 FLT3 抑制剂,IC50 分别为 47、12 nM。RSH-7 诱导细胞凋亡 (apoptosis) 并显示抗增殖活性。RSH-7 抑制 BTK 和 FLT3 信号转导并显示出抗肿瘤活性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1055 | 有现货 |
|
| 10MG | ¥1701 | 有现货 |
|
| 25MG | ¥2604 | 有现货 |
|
| 50MG | ¥3460 | 有现货 |
|
| 100MG | ¥4608 | 有现货 |
|
| 200MG | ¥6147 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称RSH-7
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述RSH-7 是一种有效的 BTK 和 FLT3 抑制剂,IC50 分别为 47、12 nM。RSH-7 诱导细胞凋亡 (apoptosis) 并显示抗增殖活性。RSH-7 抑制 BTK 和 FLT3 信号转导并显示出抗肿瘤活性。
-
产品描述RSH-7 is a potent BTK and FLT3 inhibitor with IC50s of 47, 12 nM, respectively. RSH-7 induces apoptosis and shows antiproliferative activities. RSH-7 inhibits BTK and FLT3 signaling and shows anti-tumor activity.
-
体外实验RSH-7 (1-1000 nM; 72 h) shows antiproliferative activities with IC50s of 17, 3, 11, 930 nM for Jeko-1, MV-4-11, Molt4, K562 cells, respectively.RSH-7 (30, 150, 750 nM; 72 h) decreases the expression of p-BTK (TYR223), p-PLCγ(Tyr1217), p-FLT3 (Tyr589), p-STAT5 (TYR694) in a dose-dependent manner.RSH-7 (30, 150, 750 nM; 72 h) induces apoptosis and increases the expression of BAX, p53, cleaved caspase 3 in a dose dependen manner in jeko-1 cells..Cell Viability Assay Cell Line:Jeko-1, MV-4-11, Molt4, K562 cells Concentration:1-1000 nM Incubation Time:72 h Result:Showed antiproliferative activities with IC50s of 17, 3, 11, 930 nM for Jeko-1, MV-4-11, Molt4, K562 cells, respectively.Western Blot Analysis Cell Line:jeko-1 cells Concentration:30, 150, 750 nM Incubation Time:72 h Result:Reduced both BTK, PLCγ2, FLT3 and STAT5 phosphorylation in a dose-dependent manner.Apoptosis Analysis Cell Line:jeko-1 cellsConcentration:30, 150, 750 nM Incubation Time:72 h Result:Dose-dependently induced cell apoptosis and upregulated the expression of pro-apoptotic protein BAX, p53, cleaved caspase 3.
-
体内实验RSH-7 (25, 50 mg/kg; i.p.; daily for 16 days) shows anti-tumor activity with significantly and dose-dependently suppresses the tumor growth in mouse.Animal Model:Female NOD/SCID mice (jeko-1 cell-inoculated xenograft NOD/SCID mice models)Dosage:25, 50 mg/kg Administration:I.p.; daily for 16 days Result:Suppressed tumor growth in a dose-dependent manner, with tumor growth inhibition (TGI) values of 66.95% and 79.78% at doses of 25 and 50 mg/kg,Animal Model:Female NOD/SCID mice (MV4-11 cell-inoculated xenograft NOD/SCID mice models)Dosage:10, 20 mg/kg Administration:I.p.; daily for 21 days Result:Significantly and dose-dependently suppressed the tumor growth with the TGI rates of 74.23% and 94.84% at the dosage of 10 and 20 mg/kg, respectively.
-
同义词——
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis | FLT | BTK
-
研究领域——
-
适应症——
化学信息
-
CAS Number2764609-97-2
-
分子量436.49
-
分子式C22H25FN8O
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 83.33 mg/mL (190.91 mM; 超声助溶 )
-
SMILESN(C1=C(C(NN)=O)C=CC=C1)C2=NC(NC3=CC=C(C=C3)N4CCN(C)CC4)=NC=C2F
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Ran F, et al. Development of novel hydrazidoarylaminopyrimidine-based BTK/FLT3 dual inhibitors with potent in vivo anti-hematological malignancies effects. Eur J Med Chem. 2023 Jan 5;245(Pt 1):114913.?
产品手册
关联产品
-
BTM-3528
BTM-3528 是线粒体蛋白酶 OMA1 的激活剂,介导线粒体整合应激反应 (ISR) 的过度激活。BTM-3528 刺激 OMA1 依赖性 DELE1 和 OPA1 裂解、线粒体断裂。BTM-3528 激活 eIF2α 激酶 HRI,诱导细胞生长停滞和细胞凋亡 (apoptosis)。BTM-3528 对多种 DLBCL 细胞系具有抗癌活性,在异种移植人 DLBCL SU-DHL-10 细胞的小鼠模型中具有体内抑制效力。
-
N-Hexanoyl-D-sphingo...
C6-神经酰胺是一种神经酰胺途径激活剂,具有对抗多种癌细胞系的活性。 C6-神经酰胺可作为化疗药物的佐剂,增强抗肿瘤作用。
-
KS106
KS106 是一种有效的 ALDH 抑制剂,对 ALDH1A1、ALDH2 和 ALDH3A1 的 IC50 分别为 334、2137、360 nM。KS106 具有低毒性的抗增殖和抗癌作用。KS106 显著增加 ROS 活性、脂质过氧化和有毒醛的积累。KS106 诱导细胞凋亡 (apoptosis) 和细胞周期停滞在 G2/M 期。
021-51111890
购物车()
sales@molnova.cn

